Meeting slides
Interactive presentation

The EGPA Patient Experience

Marge W., a patient with EGPA, discusses her early symptoms, diagnosis, and real life experience living with this rare and burdensome disease.
Suggested Readings
Linked Resources

Clinical Practice Guidelines

2021 American College of Rheumatology (ACR)/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody– associated vasculitis.

Chung SA, et al. Arthritis Rheumatol. 2021;73(8):1366-1383.

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology (EULAR) classification criteria for eosinophilic granulomatosis with polyangiitis.

Grayson PC, et al. Ann Rheum Dis. 2022;81(3):309-314.

EULAR recommendations for the management of ANCA- associated vasculitis: 2022 update.

Hellmich B, et al. Ann Rheum Dis. 2024;83(1):30-47. 

Patient Advocacy Organizations and Resources

American College of Rheumatology (ACR)

ACR is a global medical society that serves physicians, health professionals, and scientists worldwide with the goal of advancing research and training to improve the health of people with rheumatic diseases.

American Thoracic Society (ATS)

The mission of the ATS is to improve health worldwide by advancing research, clinical care, and public health in respiratory disease, critical illness, and sleep disorders.

European Alliance of Associations for Rheumatology (EULAR)

EULAR represents people with rheumatic and musculoskeletal diseases, health professionals in rheumatology, rheumatologists, researchers and scientific societies in the field of rheumatology of all the European nations.

Vasculitis Foundation

The mission of the Vasculitis Foundation is to build upon the collective strength of the vasculitis community, the Foundation supports, to inspire and empower individuals with vasculitis and their families through a wide range of education, research, clinical, and awareness initiatives.

 

Related activities
Webcast 
1.50 AMA PRA

Turning the Tide on Eosinophilic Granulomatosis With Polyangiitis

New Targeted Strategies to Reduce Disease Burdens